Systematic review of health state utility values for acute myeloid leukemia
Anna Forsythe,1 Patricia S Brandt,2 Mike Dolph,1 Sachin Patel,3 Adrian Paul J Rabe,1 Gabriel Tremblay1 1Purple Squirrel Economics, New York, NY, 2Novartis Pharmaceuticals, East Hanover, NJ, USA; 3Novartis Pharmaceuticals UK Limited, Frimley, Camberley, Surrey, UK Background: Cost-utility analyses fo...
Saved in:
Main Authors: | Forsythe A (Author), Brandt PS (Author), Dolph M (Author), Patel S (Author), Rabe APJ (Author), Tremblay G (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
by: Mohammad Hadi Sadeghian, et al.
Published: (2018) -
Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review
by: Forsythe A, et al.
Published: (2019) -
Immunotherapies for Acute Myeloid Leukemia
Published: (2020) -
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
by: Álvaro Pinto-Merino, et al.
Published: (2022) -
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
by: Juan Eduardo Megías-Vericat, et al.
Published: (2022)